Hand in hand: molecular testing and treatment options

I had an exciting discussion this morning, and I feel so empowered. One of the things I plan to do is to set up genetic screening for all the atypical patients with Type 1 diabetes ( or I should call this Juvenile Diabetes). We may be able to identify patients with Wolfram syndrome and other rare forms of diabetes. What we need is treatment for each rare form of diabetes. If there is no treatment, the genetic screening is still helpful, but the benefit is modest. On the other hand, if there is any treatment to delay the progression, our genetic screening is quite beneficial for patients.

Thank you for reading this blog. I always appreciate your support. Thank you, Thank you, Thank you.


Fumi Urano